|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
1991-8-14
|
|
pubmed:abstractText |
It is known from a variety of experimental systems that the ability of tumor cells to grow locally and metastasize can be affected by the presence of adjacent normal tissues and cells, particularly mesenchymally derived stromal cells such as fibroblasts. However, the comparative influence of such normal cell-tumor cell interactions on tumor behavior has not been thoroughly investigated from the perspective of different stages of tumor progression. To address this question we assessed the influence of normal dermal fibroblasts on the growth of human melanoma cells obtained from different stages of tumor progression. We found that the in vitro growth of most (4 out of 5) melanoma cell lines derived from early-stage radial growth phase or vertical growth phase metastatically incompetent primary lesions is repressed by coculture with normal dermal fibroblasts, suggesting that negative homeostatic growth controls are still operative on melanoma cells from early stages of disease. On the other hand, 9 out of 11 melanoma cell lines derived from advanced metastatically competent vertical growth phase primary lesions, or from distant metastases, were found to be consistently stimulated to grow in the presence of dermal fibroblasts. Evidence was obtained to show that this discriminatory fibroblastic influence is mediated by soluble inhibitory and stimulatory growth factor(s). Taken together, these results indicate that fibroblast-derived signals can have antithetical growth effects on metastatic versus metastatically incompetent tumor subpopulations. This resultant conversion in responsiveness to host tissue environmental factors may confer upon small numbers of metastatically competent cells a growth advantage, allowing them to escape local growth constraints both in the primary tumor site and at distant ectopic tissue sites.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-1899443,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-2167000,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-2197032,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-2203339,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-2335570,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-2402505,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-2404378,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-2426138,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-2457913,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-2556408,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-2713858,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-2733038,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-2752417,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-3056609,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-3316051,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-3325049,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-3357198,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-3463969,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-3537791,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-365241,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-3902250,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-3944188,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-4019594,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-4069218,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-4575201,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-6250325,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-6333426,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068080-7284994
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0027-8424
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
88
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
6028-32
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:2068080-Adipose Tissue,
pubmed-meshheading:2068080-Animals,
pubmed-meshheading:2068080-Cattle,
pubmed-meshheading:2068080-Cell Communication,
pubmed-meshheading:2068080-Cell Division,
pubmed-meshheading:2068080-Cells, Cultured,
pubmed-meshheading:2068080-DNA Replication,
pubmed-meshheading:2068080-Endothelium, Vascular,
pubmed-meshheading:2068080-Fibroblasts,
pubmed-meshheading:2068080-Humans,
pubmed-meshheading:2068080-Infant, Newborn,
pubmed-meshheading:2068080-Male,
pubmed-meshheading:2068080-Melanoma,
pubmed-meshheading:2068080-Skin,
pubmed-meshheading:2068080-Skin Physiological Phenomena
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression.
|
|
pubmed:affiliation |
Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, Toronto, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
